11: Prevention of CVD; Drugs on CVD

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/99

encourage image

There's no tags or description

Looks like no tags are added yet.

100 Terms

1
New cards

Aims of using drugs on CV system and what do they adjust

rate and rhythm, force of myocardial contraction, peripheral resistance and blood flow, blood volume

2
New cards

ways in which drugs influence the heart

intropy, chronotropy, dromotropy, lusitropy

3
New cards

intropy drugs

alter contractility

4
New cards

chronotropy drugs

alter heart rate

5
New cards

dromotropy drugs

alter electrical conduction

6
New cards

lusitropy drugs

relaxation

7
New cards

types of abnormality in heart rate or rhytm

bradycardia, atrial flutter, atrial fibrillation, tachycardia, ventricular fibrillation, sinus tachycardia

8
New cards

types of tachycardia

sinus, ventricular, supraventricular

9
New cards

Supraventricular tachycardia

tachycardia above bundle

10
New cards

ectopic pacemaker activity as a cause of arrhythmia

damaged area of myocardium becomes depolarised and spontaneously active. latent pacemaker region activated due to ischaemia which dominates over SA node

11
New cards

causes of arrythmias

ectopic pacemaker activity, afterdepolarisations, re-entry loop

12
New cards

afterdepolarisations as a cause of arrythmia

abnormal depolarisations following AP. prolonged duration of action potential (shown as longer QT interval) causes increased cytosolic calcium and allows afterdepolarisations to occur which triggers a premature AP to fire

13
New cards

re-entry loop types as a cause of arrythmia

conduction delay and accessory delay

14
New cards

conduction delay as a result of conduction damage in unidirectional block is a re-entry mechanism as a cause of arrythmia . how does it set up a circus of excitation

bifurcation in conduction branches turn in on themselves adn cancel out the AP. however, if there is a conduction block, the signal conducts stronger on one side than the other causing a re-entry of the signal in the other side through a longer, delayed route. this side is no longer in refractory period so signal can propagate.

15
New cards

re-entry loops as a re-entrant mechanism for generating arrhythmias

lead to atrial fibrillation around pulmonary veins and sometimes associated with cardiac surgery where there is damage to the veins

16
New cards

Wolff-Parkinson-White Syndrome and bundle of kent

additional point of conductivity between atria and ventricles. an additional accessory pathway electrically links atria and ventricles known as bundle of kent which is a bypass tract

17
New cards

Wolff-Parkinson-White Syndrome

Most common type of ventriuclar pre-excitation sydnrome. Abnormal fast accessory conduction pathway from atria to venricle bypasses the rate-slowing AV node causing a delta wave and widening QRS with shortened PR interval. Could lead to a reentrant circuit and suprvaventicular tachy.

18
New cards

classes of arrhythmic drugs

1. blocks VGNa channels

2. antagonists of B-adrenoreceptors

3. block K+ channels

4. block Ca2+ channels

5. other (adenosine, Funny channel blockers and magnesium)

19
New cards

blocker of VGNa channels in cardiomyocytes not AVN or SAN in a negative dromatropic fashion

lidocaine, blocks Na+ channels in open or inactive state. dissociates rapidly in time for next AP which slows AP conduction across cardiomyocytes to correct arrythmias

20
New cards

why do class I drugs of the heart only work on cardiomyocytes not SAN or AVN

bc SAN and AVN use calcium for action potential not sodium

21
New cards

IV lidocaine for MI in acute settings not prophylactically as a class I drug of rhythm and rate

following MI pt presents with ventricular tachycardia as damaged areas of myocardium may be depolarised and automatically fire. as more Na+ channels are open in depolarised tissue, lidocaine blocks these channels to prevent automatic firing.

22
New cards

example of class II rate and rhythm controller of heart (beta adrenoreceptor antagonists)

propanolol, atenolol

23
New cards

b-adrenoreceptor antagonist as a class II rate and rhythm controller of heart

MI causes increased sympathetic activity. B blockers prevent ventricular arrhythmias as a result of the sympathetic activity.

block sympathetic action by antagonising b1-adrenoreceptors of the heart. also slow conduction in AVN to prevent supraventricular tachycardias.

decrease slope of pacemaker potential in SA

24
New cards

why are b-blockers useful for angina

reduces O2 demand and so reduces myocardial ischaemia which is beneficial following MI

25
New cards

class three drugs

(K+ channel blockers)

prolong action potential by blocking K+ channels. strengthen absolute refractory period so prevents another AP occurring too soon.

26
New cards

why K+ channel blockers (class III) not used generally

bc they can be pro-arrhymic aside from amidarone

27
New cards

amidarone

Class III K+ channel blocker but also has other actions. used to treat tachycardia associated with wolff parkinson-white syndrome

28
New cards

class IV drugs (block ca2+ channels)

decreases slope of pacemaker AP in SAN and decreases nodal conduction and force of contraction (negative inotropy). some coronary and peripheral vasodilation.

29
New cards

example class IV drugs (block ca2+ channels)

verapamil

30
New cards

why class IV drugs on SAN and not class I

because SAN has calcium channels to initiate AP not sodium channels

31
New cards

dihydropyridine Ca2+ channel blockers

not effective in preventing arrhythmias but act on vascular smooth muscle

32
New cards

adenosine as class V anti arrhythmitic

acts on A1 receptors at AVN. enhances K+ conductance resulting in hyperpolarisation of cells of conducting tissue causing stopped heart momentarily and resets rhythm.

33
New cards

a1 receptor of AV node

g protein coupled receptor like adrenergic. activation of a1 enhances potassium conduction

34
New cards

why adenosine given IV

because it is endogenous. if given orally it will just be metabolised

35
New cards

define heart failure

failure of heart to provide sufficient output to meet body's requirements

36
New cards

goal of heart failure treatment

reduce work load of heart by reducing preload and afterload using positive ionotropes to increase cardiac output with positive ionotropes or ace inhibitors

37
New cards

positive ionotropes used in heart failure

b-adrenergic agonists eg adrenaline and dobutamine. or cardiac glycosides for atrial fibrillation.

38
New cards

how do ace inhibitors reduce work load of heart

prevention of ag1 to ag2 by limiting angiotensin converting enzyme. ag2 is a vasoconstrictor and aldosterone which increases water reabsorption . so without a2 you have decrease vasomotor tone so decrease in blood pressure so reduced afterload. decreased fluid retention causes decrease in blood volume so reduced preload of the heart.

39
New cards

Angiotensin II Receptor Blockers (ARBs)

have similar effects to ACE inhibitors in heart failure

40
New cards

losartan

angiotensin 2 receptor blocker

41
New cards

drugs that reduce the work load of heart

b-blockers, diuretics, ace inhibitors, arbs

42
New cards

positive ionotropy

increase myocardial contractility

43
New cards

cardiac glycosides as positive ionotropes

cardiac glycosides improve symptoms but now used in atrial fibrillation

44
New cards

positive ionotropic drugs

cardiac glycosides, digotoxin as a prototype

45
New cards

digoxin as a positive ionotrope

blocks Na+/K+ase

46
New cards

lusitropy

relaxation of myocardium following excitation contraction coupling by removing calcium into sarcopasmic reticulum to promote relaxation. it is diastolic in function

47
New cards

ionotropy

contractility. systolic function

48
New cards

factors hat produce positive lusitropy

b-antagonists: phosphorylate phospholamban via cAMP.

49
New cards

phospholamban

antagonist of SERCA in non-phosphorylated state

50
New cards

factors that produce negative lusitropy

high cytosolic calcium, impaired sarcoplasmic reticulum calcium ATPase (serca). increased affinity of troponin C: alkalosis increases calcium sensitivity. cardiac glycosides indirectly effects via sodium pump, b-blockers

51
New cards

Cardiac Glycosides MOA

calcium pumped out of cells by sodium-calcium exchanger. driven by Na+ moving down conc gradient. block Na+/K+ase = rise in Na+ intracellularly so Ca+ retained in cells due to decrease in exchanger. more Ca2+ stored in SR so increased force of contraction so positive inotropic effect

52
New cards

how do cardiac glycosides impact on heart chronotropically

increased vasal activity through central pathway to stimulate Ach which stimulates muscarinic receptors to slow AV conduction and slow hr

53
New cards

drugs which increase myocardial contractility and speed of relaxation

b-adrenoreceptor agonists eg dobutamine. acts on b1 receptors

54
New cards

when would you use dobutamine

in cardiogenic shock, acute but reversible heart failure

55
New cards

how do b-adrenoreceptor agonists work

G prt coupled receptor in membrane

Gpcr

Signals through GSG protein which modulates activity of adenyl cyclase . Stimulates cAMP, promotes PKA action, phosophorylate proteins

Inc phospholamban and effects SERCA pump by inhibiting so prevents Ca2+ storage and increase in intracellular calcium increases contractility

56
New cards

pharmacological treating of angina by reducing work load of the heart

ACE/arb; b-blockers; ca2+ channel antagonists; organic nitrates; funny channel blockers

57
New cards

pharmacological treating of angina by improving blood supply to heart

ca2+ antagobists

58
New cards

pharmacological treating of angina by cholestrol reduction

statins

59
New cards

surgical interventions for angina

angiography, stents, revascularise

60
New cards

organic nitrates MOA

organic nitrates react with SH- (thiols) in vascular smooth muscle to release NO2- . NO2- is reduced to NO whch is a vasodilator

61
New cards

organic nitrate examples

glyceryl trinitrate; isosorbide mononitrate; isosorbide dinitrate

62
New cards

how does NO cause vasodilation

NO activates guanylate cyclase which converted to cGMP works with PKG to lower intracellular Ca2+ to relax vascular smooth muscle

63
New cards

NO vasodilator. how does alleviate symptoms - primary action

acts on venous system to dilate to lower preload; reduces venous pressure; which reduces workload of heart. heart fills less so force of contraction reduced according to starlings law so this reduces O2 demand

64
New cards

NO vasodilator. how does alleviate symptoms - secondary action

action on coronary arteries improves O2 delivery to ischaemic myocardium and acts on collateral arteries rather than arterioles

65
New cards

organic nitrates on collateral arteries from atheromatous plaques

plaques cause poor perfusion nitrate dilates collateral. ichaemic area blood flow increases nitrate dilates vessles to perfusion

66
New cards

heart conditions carry an increased risk of thrombus formation

atrial fibrillation; acute myocardial infarction; mechanical prosthetic heart valves

67
New cards

antithrombotic drugs for clotting cascade

IV heparin; fractured hearin (subcutaneous injection); fondaparinux; warfarin orally; dabigatran, apixaban, rivaroxaban

68
New cards

IV heparin

inhibits thrombin, short term action

69
New cards

warfarin orally MOA

blocks activation/recycling victamin K (epoxide reductase complex 1 inhibitor) inhibits synthesis or hepatic clotting factors II, VII, IX, X. used long term

70
New cards

Novel Oral Anticoagulants

thrombin inhibitor; factor Xa inhibitor

thrombin inhibitor: dabigatran

factor xa inhibitors: apixaban, rivaroxaban

71
New cards

vk clotting factors

II, VII, IX, X

72
New cards

antiplatelet drugs following acute MI or high risk MI

aspirin

73
New cards

antiplatelet drug dipyridamol how

phosphodiesterase inhibitopm

74
New cards

how antiplatet clopidogrel work

inhibits ADP dependent platelet aggregation

75
New cards

behavioural rf for heart diseases

alcohol, obesity, physical activity, tobacco use, unhealthy diet

76
New cards

unhealthy diet

rich in salt, sugar, fat and calories

77
New cards

metabolic risk factors for cvd

raised BP, raised blood sugar, raised blood lipids, overweight and obesity

78
New cards

rf for CVD

poverty, advancing age, sex, genetics, psychological factors (stress and depression)

79
New cards

primary prevention of CHD

prevents disease from occuring in those at risk eg provide smoking cessation advice to someone with no history of CHD

80
New cards

secondary prevention of CHD

identify high risk individuals and prevent disease progression eg provision of lipid lowering medications to those with CHD

81
New cards

tertiary prevention of CHD

prevent recurrence of MI. eg revascularisation after MI for severe CHD cases

82
New cards

policies of heart disease prevention

banning tobacco smoke from public places to protect people. warning about dangers of tobacco use. enforcing bans on tobacco advertising, raising taxes on alcohol, replacing transfat in food with polyunsaturated fat, public awareness of diet and physical activity

83
New cards

QRISK

primary, secondary or tertiary prevention

primary

84
New cards

QRISK

ethnicity, family hx, deprivation, BP treatment, BMI, RA, CKD, AF. works out 10 year risk of MI/stroke

85
New cards

QRISK >10%

advised to start statins

86
New cards

obesity/ reducing rf for HD advice

mediterranean diet, childhood obesity through change4life, low salt diets, alcohol less than 14 units a week, peer supported weight loss programmes

87
New cards

psychological factors in heart disease

individual differences: optimism, hostility, stress

mood: depression, anxiety

88
New cards

resources for psychological processes in heart disease

coping, support, religion, midfulness, hypnosis, cbt, excercise, psychotherapy, social support, motivational interviewing, neuroendocrine and immune review

89
New cards

biological factors in heart disease

genetics, sex, age, fhx, ethnicity, exposure to viruses and toxins, injury, medical treatment

90
New cards

health behaviours factors in HD

sleep, excersise, sun exposure, screening attendance, alcohol, drug use, smoking, sexual behaviours, adherence, vaccination

91
New cards

neuroendocrine factors in heart disease

HPA activation, cortisol, oestrogen, testosterone

92
New cards

immune mechanisms as factors for heart disease

immune responses, wound healing factors from cytokines

93
New cards

depression increases cardio events. direct pathway, hospital readmission and mortality

pro-inflammatory (chronic stressor) and associated with increased inflammatory measures (CRP, cortison), increases heart rate, glucose adn BP. parasympathetic control of heart reduced in depressed patients so increased susceptibility to cardiac arrhythmias and sudden death

94
New cards

how does depression increase cardiac events indirectly

increases risk of smoking, obesity, decreased exercise and adherence after cardiac event, increasing risk of atherosclerosis

95
New cards

dose response relationship in depression and cardiac events

more severe depression, increased risk of cardiac death

96
New cards

questions for depression

energy level, sleeping, mood, anxious or worried, undue pressure at home/work, difficulty unwinding after work or at the end of the day, who do you go to for support

97
New cards

Ornish Program for Reversing Heart Disease

non surgical or pharmalogical. dose response manner and saves money per pt

social: group support involving partners

psychological: stress management (meditation, yoga)

physical: low fat, vegetarian diet, exercise, stopping smoking

98
New cards

non surgical or pharmalogical HD treatment

multidisciplinarhy cardiac rehabillitation. nutrition counselling, education, RF management (eg smoking cessation) physical activity conselling, psychological interventions (stress management)

99
New cards

pros of multidisciplinary cardiac rehab

less time in hospital, improved QOL, reduced mortality, non surgical/pharmalogical

100
New cards

cons of multidiscpilinary cardiac rehab

poor attendance (travel, mental health, dislike of groups)